logo
Plus   Neg
Share
Email

Pfizer Q2 Revenues Up 2% Operationally; Updates 2019 Guidance

Pfizer Inc. (PFE) said it reported solid second-quarter financial results, with total company revenues up 2% operationally. Performance was primarily driven by 6% volume-driven operational growth in the company's Biopharma business.

For the second-quarter, adjusted EPS was $0.80 compared to $0.77, a year ago. On average, ten analysts polled by Thomson Reuters expected the company to report profit per share of $0.75, for the quarter. Analysts' estimates typically exclude special items. Reported net income improved 30% year-on-year to $5.05 billion.

Second-quarter revenues totaled $13.26 billion, a decrease of 2%, compared to the prior-year quarter. Analysts expected revenue of $13.4 billion, for the quarter. Second-quarter Biopharma revenues totaled $9.6 billion, up 6% operationally. Upjohn revenues were $2.8 billion, down 7% operationally.

During the first six months of 2019, Pfizer returned $12.9 billion directly to shareholders, through a combination of: $4.0 billion of dividends; and $8.9 billion of share repurchases. As of July 30, 2019, Pfizer's remaining share repurchase authorization was $5.3 billion.

The company updated its 2019 financial guidance primarily to reflect the anticipated formation of the Consumer Healthcare Joint Venture with GlaxoSmithKline plc and the anticipated near-term completion of the Array BioPharma Inc. acquisition. Excluding the changes to guidance related to pending business development activities, the company's 2019 financial guidance is unchanged.

For 2019, Pfizer now projects adjusted EPS in a range of $2.76 to $2.86, updated from prior guidance range of $2.83 to $2.93. Revenues are anticipated to be in the range of
$50.5 billion to $52.5 billion, revised from previous guidance range of $52.0 billion to $54.0 billion. Analysts expect the company to report profit per share of $2.91 on revenue of $53.28 billion.

Separately, Pfizer and Mylan announced a definitive agreement to combine Upjohn and Mylan to create a new global pharmaceutical company. Pfizer shareholders would own 57% and Mylan shareholders would own 43% of the combined new company.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hongkong Sun Rise Trading Ltd. has recalled about 151,400 units of Kobalt Cordless Electric chainsaws and about 106,520 units of Kobalt Cordless Electric pole saws for possible laceration hazard, according to two separate statements issued by the U.S. Consumer Product Safety Commission. These include 1,400 chainsaws and 120 pole saws sold in Canada. Branded food company Hormel Foods Corp. (HRL) announced Friday that its Hormel Black Label Breakfast Food Truck will hit the road with free sample event of the popular brand's new Hormel Black Label Oven-Baked Egg Bites. The samples come in three variants - with Bacon, with Chorizo and with Bacon and... United Airlines has rolled out an interactive online "Map Search" feature for its customers in collaboration with search giant Google. The new feature is powered by Google Flight Search Enterprise Technology. United is claimed to be the first airline in the U.S. to add this feature. The new feature, available on United.com, allows customers to easily search, compare and purchase flight tickets.
Follow RTT